Clinical Trial Update: Adenovirus Vaccine for Malaria [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of an adenovirus-based malaria vaccine sponsored by NIAID has completed. The trial focused on Plasmodium falciparum infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Adenovirus-based malaria vaccine (Adenovirus vector-based malaria vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plasmodium Falciparum Infection | Phase 1 | Status: COMPLETED